255 related articles for article (PubMed ID: 16205772)
1. Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning.
Frank SJ; Chao KS; Schwartz DL; Weber RS; Apisarnthanarax S; Macapinlac HA
Nat Clin Pract Oncol; 2005 Oct; 2(10):526-33. PubMed ID: 16205772
[TBL] [Abstract][Full Text] [Related]
2. Role of PET/CT in treatment planning for head and neck cancer patients undergoing definitive radiotherapy.
Arslan S; Abakay CD; Sen F; Altay A; Akpinar T; Ekinci AS; Esbah O; Uslu N; Kekilli KE; Ozkan L
Asian Pac J Cancer Prev; 2014; 15(24):10899-903. PubMed ID: 25605198
[TBL] [Abstract][Full Text] [Related]
3. [Clinical application of PET and PET/CT in radiotherapy of head and neck cancer].
Chen B; Gao L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):425-30. PubMed ID: 16900650
[TBL] [Abstract][Full Text] [Related]
4. The evolving role of positron emission tomography-computed tomography in organ-preserving treatment of head and neck cancer.
Garg MK; Glanzman J; Kalnicki S
Semin Nucl Med; 2012 Sep; 42(5):320-7. PubMed ID: 22840597
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
6. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
[TBL] [Abstract][Full Text] [Related]
7. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes.
Ford EC; Kinahan PE; Hanlon L; Alessio A; Rajendran J; Schwartz DL; Phillips M
Med Phys; 2006 Nov; 33(11):4280-8. PubMed ID: 17153406
[TBL] [Abstract][Full Text] [Related]
8. Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images.
Yu H; Caldwell C; Mah K; Poon I; Balogh J; MacKenzie R; Khaouam N; Tirona R
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):618-25. PubMed ID: 19683403
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography/computed tomography for target delineation in head and neck cancers.
Ahn PH; Garg MK
Semin Nucl Med; 2008 Mar; 38(2):141-8. PubMed ID: 18243850
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.
Vernon MR; Maheshwari M; Schultz CJ; Michel MA; Wong SJ; Campbell BH; Massey BL; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):678-84. PubMed ID: 18262086
[TBL] [Abstract][Full Text] [Related]
12. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
13. The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy.
Nawara C; Rendl G; Wurstbauer K; Lackner B; Rettenbacher L; Datz L; Studnicka M; Sedlmayer F; Pirich C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):191-201. PubMed ID: 22402822
[TBL] [Abstract][Full Text] [Related]
14. Variability of gross tumor volume delineation in head-and-neck cancer using PET/CT fusion, Part II: the impact of a contouring protocol.
Berson AM; Stein NF; Riegel AC; Destian S; Ng T; Tena LB; Mitnick RJ; Heiba S
Med Dosim; 2009; 34(1):30-5. PubMed ID: 19181253
[TBL] [Abstract][Full Text] [Related]
15. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
16. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
17. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis LW
Head Neck; 2005 Jun; 27(6):494-502. PubMed ID: 15772951
[TBL] [Abstract][Full Text] [Related]
18. A new role of PET/CT for target delineation for radiotherapy treatment planning for head and neck carcinomas.
Zygogianni A; Kyrgias G; Kouvaris J; Pistevou-Gompaki K; Kouloulias V
Hell J Nucl Med; 2012; 15(2):139-43. PubMed ID: 22833861
[TBL] [Abstract][Full Text] [Related]
19. "Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763).
Schinagl DA; Troost EG; Kaanders JH
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1629; author reply 1629. PubMed ID: 19515513
[No Abstract] [Full Text] [Related]
20. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
